Xenon Pharmaceuticals
XENE
Xenon Pharmaceuticals (XENE) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $81.00 from $82.00 | Aug 7, 2026 |
| JP Morgan | Maintained | Overweight | $82.00 from $80.00 | May 27, 2026 |
| JP Morgan | Maintained | Overweight | $80.00 from $77.00 | May 12, 2026 |
| Needham | Maintained | Buy | $78.00 from $80.00 | May 8, 2026 |
| RBC Capital | Maintained | Outperform | $82.00 from $80.00 | May 8, 2026 |
| Wedbush | Maintained | Outperform | $63.00 from $64.00 | Mar 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $74.00 from $53.00 | Mar 10, 2026 |
| Deutsche Bank | Maintained | Buy | $90.00 from $56.00 | Mar 10, 2026 |
| Wedbush | Maintained | Outperform | $64.00 from $47.00 | Mar 10, 2026 |
| Wells Fargo | Maintained | Overweight | $68.00 from $49.00 | Mar 10, 2026 |
| Baird | Maintained | Outperform | $97.00 from $63.00 | Mar 9, 2026 |
| Needham | Maintained | Buy | $80.00 from $58.00 | Mar 9, 2026 |
| Wells Fargo | Maintained | Overweight | $49.00 from $48.00 | Feb 27, 2026 |
| Needham | Maintained | Buy | $58.00 from $55.00 | Feb 27, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $60.00 | Feb 24, 2026 |
| JP Morgan | Maintained | Overweight | $62.00 from $60.00 | Jan 9, 2026 |
| Wells Fargo | Maintained | Overweight | $48.00 from $44.00 | Dec 11, 2025 |
| JP Morgan | Maintained | Overweight | $60.00 from $57.00 | Nov 18, 2025 |
| Needham | Maintained | Buy | $55.00 | Nov 4, 2025 |
| Wells Fargo | Maintained | Overweight | $44.00 from $48.00 | Nov 4, 2025 |
Frequently asked questions
What is the latest analyst rating on XENE?
On Aug 7, 2026, RBC Capital maintained Xenon Pharmaceuticals at Outperform with a price target of $81.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.